Please provide your email address to receive an email when new articles are posted on . In the U.S. market, we currently have three newer multifocal IOLs approved for use: the Alcon Clareon PanOptix ...
FORT WORTH, Texas--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced results from a new study presented at the ...
Vivity complements Alcon’s existing IOL portfolio by providing an additional option for cataract patients to treat presbyopia A first-of-its-kind, non-diffractive lens that offers a continuous ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results